Tilray, Inc. engages in the research, cultivation, processing, and distribution of medical cannabis. The company offers its products in Argentina, Australia, Canada, Chile, Croatia, Cyprus, the Czech Republic, Germany, New Zealand, and South Africa. Tilray, Inc. was incorporated in 2018 and is headquartered in Nanaimo, Canada.
Industry, Sector and Symbol
Stock Exchange NASDAQ
Industry Medicinals & botanicals
Sub-IndustryN/A
SectorMedical
SymbolNASDAQ:TLRY
CUSIPN/A
Phone206-432-9325
Debt
Debt-to-Equity RatioN/A
Current RatioN/A
Quick RatioN/A
Price-To-Earnings
Trailing P/E RatioN/A
Forward P/E RatioN/A
P/E GrowthN/A
Sales & Book Value
Annual SalesN/A
Price / SalesN/A
Cash FlowN/A
Price / CashN/A
Book ValueN/A
Price / BookN/A
Profitability
EPS (Most Recent Fiscal Year)N/A
Net IncomeN/A
Net MarginsN/A
Return on EquityN/A
Return on AssetsN/A
Miscellaneous
Employees330
Outstanding Shares93,140,000
Market Cap$11.46 billion
Tilray (NASDAQ:TLRY) Frequently Asked Questions
What is Tilray's stock symbol?
Tilray trades on the NASDAQ under the ticker symbol "TLRY."
How were Tilray's earnings last quarter?
Tilray Inc (NASDAQ:TLRY) announced its earnings results on Tuesday, August, 28th. The company reported ($0.17) EPS for the quarter, missing the consensus estimate of ($0.09) by $0.08. The firm earned $9.70 million during the quarter, compared to the consensus estimate of $9.01 million. The company's revenue was up 94.0% on a year-over-year basis. View Tilray's Earnings History.
When is Tilray's next earnings date?
What price target have analysts set for TLRY?
3 analysts have issued 12 month target prices for Tilray's stock. Their forecasts range from $34.00 to $35.00. On average, they expect Tilray's share price to reach $34.50 in the next twelve months. This suggests that the stock has a possible downside of 70.1%. View Analyst Price Targets for Tilray.
What is the consensus analysts' recommendation for Tilray?
3 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Tilray in the last year. There are currently 2 hold ratings and 1 buy rating for the stock, resulting in a consensus recommendation of "Hold." View Analyst Ratings for Tilray.
Are investors shorting Tilray?
Tilray saw a increase in short interest during the month of August. As of August 31st, there was short interest totalling 3,499,750 shares, an increase of 97.0% from the August 15th total of 1,776,903 shares. Based on an average trading volume of 8,398,853 shares, the short-interest ratio is presently 0.4 days. Currently, 19.7% of the shares of the company are sold short. View Tilray's Current Options Chain.
Who are some of Tilray's key competitors?
Some companies that are related to Tilray include Actelion (ALIOF), STADA Arzneimittel (STDAF), USANA Health Sciences (USNA), Cronos Group (CRON), Foamix Pharmaceuticals (FOMX), Chromadex (CDXC), Mediwound (MDWD), Natural Alternatives International (NAII), Pharmacyte Biotech (PMCB), Mannatech (MTEX), China Jo-Jo Drugstores (CJJD), GLG Life Tech (GLGLF), Cyanotech (CYAN), Conversion Labs (CVLB) and ImmuDyne (IMMD).
Who are Tilray's key executives?
Tilray's management team includes the folowing people:
- Mr. Edward Wood Pastorius Jr., Chief Revenue Officer (Age 50)
- Mr. Brendan Kennedy, Pres, CEO & Director (Age 46)
- Mr. Mark Castaneda, CFO, Sec. & Treasurer (Age 53)
- Dr. Catherine Jacobson, Director of Clinical Research & Member of Medical Advisory Board
When did Tilray IPO?
(TLRY) raised $135 million in an initial public offering (IPO) on Thursday, July 19th 2018. The company issued 9,000,000 shares at $14.00-$16.00 per share. Cowen and Company acted as the underwriter for the IPO and Roth Capital Partners and Northland Securities were co-managers.
How do I buy shares of Tilray?
Shares of TLRY can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
What is Tilray's stock price today?
One share of TLRY stock can currently be purchased for approximately $115.4872.
How big of a company is Tilray?
Tilray has a market capitalization of $11.46 billion. Tilray employs 330 workers across the globe.
What is Tilray's official website?
How can I contact Tilray?
Tilray's mailing address is 1920 EASTLAKE AVENUE E., SEATTLE WA, 98102. The company can be reached via phone at 206-432-9325.
MarketBeat Community Rating for Tilray (NASDAQ TLRY)
MarketBeat's community ratings are surveys of what our community members think about Tilray and other stocks. Vote "Outperform" if you believe TLRY will outperform the S&P 500 over the long term. Vote "Underperform" if you believe TLRY will underperform the S&P 500 over the long term. You may vote once every thirty days.
